home / stock / verv / verv articles

VERV Articles, Verve Therapeutics Inc.

Stock Information
Company Name: Verve Therapeutics Inc.
Stock Symbol: VERV
Market: NASDAQ
Menu
VERV VERV Quote VERV Short VERV News VERV Articles VERV Message Board
Get VERV Alerts

News, Short Squeeze, Breakout and More Instantly...
Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Quarter | Benzinga

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, whic...
Cathie Wood's Ark Invest Sheds $6.4M Worth Of Coinbase Shares Despite Positive Market Movements, Analyst Upgrade | Benzinga

On Thursday, Cathie Wood-led Ark Invest made a significant move by selling shares of Coinbase Global Inc (NASDAQ:COIN), despite the stock’s p...

Biotech Stock Roundup: IRON, VERV Down on Study Updates, BMYs Drug News & More | Benzinga

Pipeline and regulatory updates continue to be in focus in the biotech sector. While nothing much came out of bigwigs apart from a few, shares of c...

Cathie Wood's Ark Invest Buys More Shares Of This Meta Platforms Competitor | Benzinga

On Wednesday, Cathie Wood’s Ark Invest made a significant move by purchasing additional shares of Pinterest Inc (NYSE:PINS). The PINS Trade A...
Attention Verve Therapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm | Benzinga

Investors can contact the law firm at no cost to learn more about recovering their losses ?LOS ANGELES, April 02, 2024 (GLOBE NEWSWIRE) -- The...

Nasdaq Down Over 1%; VivoPower International Shares Spike Higher | Benzinga

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dipping over 1% on Tuesday. The Dow traded down 1.07% to 39,142.53 wh...

Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session | Benzinga

Shares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss. Stryve Foods post...
Gene Therapy Side Effects: Verve Therapeutics Halts Enrollment Of Lead Gene Therapy Trial In Patients With Bad Cholesterol | Benzinga

Verve Therapeutics Inc (NASDAQ:VERV) announced an update from the Heart-1 Phase 1b trial of VERVE-101. VERVE-101 is being evaluated in pa...

Crude Oil Surges Over 1%; US Factory Orders Increase In February | Benzinga

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% on Tuesday. The Dow traded down 1.05% to 39,152.47 ...

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Verve Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm | Benzinga

LOS ANGELES, April 02, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investi...
Next 10